Gaush Meditech Expects to Post Lower H1 Profit; Shares Plummet 7%

MT Newswires Live
Jul 24

Gaush Meditech (HKG:2407) expects to report a net profit of 13.9 million yuan to 16.7 million yuan for the first half of 2026, down 53.5% to 61.3% from 35.9 million yuan a year earlier.

The company attributed the expected decline to lower revenue amid shifts in market demand driven by national policies, the termination of its agency partnership for overseas femtosecond laser-assisted cataract surgery products, and exchange rate fluctuations, according to a Thursday Hong Kong bourse filing.

Shares of the company fell over 7% in recent trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10